Drug Type Small molecule drug |
Synonyms Binaprofen, Felbinac |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC18H23NO5 |
InChIKeySWKYVGAYFCGGRP-UHFFFAOYSA-N |
CAS Registry935886-64-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain, Postoperative | NDA/BLA | CN | 10 Jul 2024 | |
Pain, Postoperative | NDA/BLA | CN | 10 Jul 2024 | |
Pain | NDA/BLA | - | - | |
Low Back Pain | Phase 3 | CN | 10 May 2021 | |
Low Back Pain | Phase 3 | CN | 10 May 2021 | |
Nephrolithiasis | Phase 3 | CN | 10 May 2021 | |
Nephrolithiasis | Phase 3 | CN | 10 May 2021 | |
Neuralgia | Phase 3 | CN | 10 May 2021 | |
Neuralgia | Phase 3 | CN | 10 May 2021 | |
Cancer Pain | Phase 3 | CN | 08 Apr 2021 |